High-intensity Lipid-lowering Therapy as the Main Position of 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
New clinical guidelines establishing algorithms for diagnosis and treatment of dyslipidaemias attracts much attention due to widespread prevalence of this cardiovascular risk factor and presence of effective methods of its correction. New lower target level of low-density lipoprotein cholesterol is specified for individuals with high cardiovascular risk. Achieving target lipid levels suggests more active use of high-intensity statin therapy regimens, if necessary in combination with other lipid-lowering drugs.